START or SMART? Timing of Antiretroviral Therapy Initiation and Cardiovascular Risk for People With Human Immunodeficiency Virus Infection

The Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection (START) study has reinforced the benefits of early initiation of antiretroviral therapy (ART). However, a notable secondary finding from that study was that immediate initiation of ART did not prevent cardiovascular disease...

Descripción completa

Detalles Bibliográficos
Autor principal: Siedner, Mark J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794943/
https://www.ncbi.nlm.nih.gov/pubmed/26989755
http://dx.doi.org/10.1093/ofid/ofw032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794943/
https://www.ncbi.nlm.nih.gov/pubmed/26989755
http://dx.doi.org/10.1093/ofid/ofw032

Ejemplares similares